Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1912 1
1951 1
1953 1
1956 1
1957 1
1962 3
1963 8
1964 7
1965 7
1966 5
1967 8
1968 11
1969 23
1970 14
1971 12
1972 27
1973 15
1974 9
1975 27
1976 16
1977 26
1978 25
1979 25
1980 22
1981 28
1982 36
1983 45
1984 33
1985 38
1986 48
1987 45
1988 46
1989 72
1990 45
1991 57
1992 56
1993 56
1994 53
1995 60
1996 62
1997 77
1998 90
1999 107
2000 108
2001 98
2002 111
2003 106
2004 99
2005 108
2006 109
2007 112
2008 129
2009 104
2010 114
2011 102
2012 137
2013 132
2014 133
2015 135
2016 150
2017 125
2018 171
2019 199
2020 195
2021 215
2022 215
2023 238
2024 205
2025 202
2026 180
2027 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,837 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis of abnormal uterine bleeding based on the FIGO classification: A systematic review and expert opinions.
Kitahara Y, Hiraike O, Ishikawa H, Kugu K, Takai Y, Yoshino O, Ono M, Maekawa R, Ota I, Iwase A; Subcommittee “Standardization of diagnosis for menstrual disorders” in Reproductive Endocrinology Committee, Japan Society of Obstetrics and Gynecology, 2018‐2022. Kitahara Y, et al. Among authors: ishikawa h. J Obstet Gynaecol Res. 2024 Oct;50(10):1785-1794. doi: 10.1111/jog.16073. Epub 2024 Sep 5. J Obstet Gynaecol Res. 2024. PMID: 39234899
A pH-sensitive binding modality allows successful transferrin receptor-mediated transcytosis of a bivalent antibody across brain barriers.
Kuhn P, Petralla S, Dabbagh F, Pegoretti V, Muranyi W, Ishikawa H, Schroten H, Fischer R, Frenzel A, Schirrmann T, Rehm M, Schwerk C, Fricker G, Kontermann R, Fullstone G. Kuhn P, et al. Among authors: ishikawa h. MAbs. 2025 Dec;17(1):2563758. doi: 10.1080/19420862.2025.2563758. Epub 2025 Sep 22. MAbs. 2025. PMID: 40983601 Free PMC article.
[Leber's hereditary optic neuropathy].
Takai Y, Yamagami A, Ishikawa H. Takai Y, et al. Among authors: ishikawa h. Rinsho Shinkeigaku. 2024 May 24;64(5):326-332. doi: 10.5692/clinicalneurol.cn-001924. Epub 2024 Apr 20. Rinsho Shinkeigaku. 2024. PMID: 38644210 Review. Japanese.
A prospective, randomized, double-blind, placebo-controlled trial of the Kampo formula daiobotanpito combined with antibiotic therapy for acute diverticulitis.
Ogawa-Ochiai K, Tsuji S, Maeda A, Ikehara H, Kawabata K, Dohmen T, Ojima E, Nakayama G, Hisabe T, Suenaga M, Kagaya T, Ishigure K, Okochi O, Hattori M, Hirai H, Kasai T, Takeda T, Yamada T, Yoshida I, Sakai M, Takehara A, Munemoto Y, Esaki M, Mochizuki Y, Nishijima K, Kitamura S, Sakai S, Hara T, Honyang L, Doyama H, Uchita K, Kodera Y, Yoshimura K, Mori K, Ishikawa H. Ogawa-Ochiai K, et al. Among authors: ishikawa h. Sci Rep. 2025 Jul 1;15(1):21069. doi: 10.1038/s41598-025-07385-9. Sci Rep. 2025. PMID: 40595170 Free PMC article. Clinical Trial.
A collaborative step forward in hemoptysis research.
Ishikawa H, Yamaguchi Y. Ishikawa H, et al. Respir Investig. 2024 Jul;62(4):606-607. doi: 10.1016/j.resinv.2024.04.013. Epub 2024 May 3. Respir Investig. 2024. PMID: 38703521 No abstract available.
Phosphodiesterase 3 inhibitors boost bone outgrowth.
Kawabe T, Ichimura A, Yasue T, Li J, Ishikawa H, Kim GE, Nagatomo H, Minamino N, Ueda Y, Ito H, Nishi M, Takeshima H. Kawabe T, et al. Among authors: ishikawa h. Br J Pharmacol. 2025 Sep;182(18):4327-4342. doi: 10.1111/bph.70087. Epub 2025 Jun 2. Br J Pharmacol. 2025. PMID: 40456620 Free article.
IgG4-related disease in the Japanese population: a whole-genome sequencing study.
Zhang YO, Iwasaki T, Kawaguchi T, Takahashi H, Kawaguchi S, Kanno A, Yamaguchi I, Kubota K, Dobashi H, Nagasaki M, Yamamoto M, Takahashi M, Shimizu M, Ikeura T, Matsui S, Kanda M, Nakamura K, Yokoyama K, Azumi A, Masaki Y, Mizushima I, Kurita Y, Seno H, Origuchi T, Yazumi S, Hirano K, Masamune A, Mizuno N, Shimada H, Moriyama M, Hori Y, Kodama Y, Saeki T, Kin T, Kawanami C, Asada M, Akamizu T, Nakamura A, Oshima K, Tanaka Y, Yoshifuji H, Kamisawa T, Kimura T, Umehara H, Ishikawa H, Chiba T, Okazaki K, Mimori T, Nakamura S, Kawano M, Matsuda F; Japanese IgG4-Related Disease Working Consortium. Zhang YO, et al. Among authors: ishikawa h. Lancet Rheumatol. 2026 Jan;8(1):e11-e22. doi: 10.1016/S2665-9913(25)00195-X. Epub 2025 Nov 3. Lancet Rheumatol. 2026. PMID: 41197642 Free article.
Intranasal phage therapy overcomes antibody neutralization challenges in pulmonary Pseudomonas aeruginosa infections.
Wannigama DL, Shao J, Sun H, Wang Y, Hurst C, Monk PN, Amarasiri M, Phattharapornjaroen P, Ditcham WGF, Htun TS, Luk-In S, Shimotai Y, Ngamwongsatit N, Ishikawa H, Ragupathi NKD, Pletzer D, Kanjanabuch T, Khatib A, Miyanaga K, Cui L, Shibuya K, Higgins PG, Kicic A, Hongsing P, Zhao J, Abe S, Hamamoto H. Wannigama DL, et al. Among authors: ishikawa h. Arch Microbiol. 2025 Oct 18;207(12):310. doi: 10.1007/s00203-025-04526-6. Arch Microbiol. 2025. PMID: 41108387
Clinical profile of IgG4-related disease in Japan based on the rare disease data registry.
Yamamoto M, Kanda M, Mizushima I, Kanno A, Umemura T, Ikeura T, Kodama Y, Dobashi H, Tanaka Y, Masamune A, Moriyama M, Saeki T, Matsui S, Origuchi T, Masaki Y, Asada M, Umehara H, Seno H, Naitoh I, Yamamoto S, Iwasaki E, Kubota K, Tanoue S, Nishino T, Tsuboi H, Matsumoto Y, Isayama H, Goto H, Notohara K, Uchida K, Kawabe K, Yamada K, Kasashima S, Takahira M, Sato Y, Kawachi I, Yamaguchi I, Okazaki K, Nakamura S, Matsuda F, Ishikawa H, Kawano M; Patient Registry Committee, Research Program for Intractable Disease by the Ministry of Health, Labour and Welfare (MHLW), Japan. Yamamoto M, et al. Among authors: ishikawa h. Immunol Med. 2025 Sep;48(3):192-202. doi: 10.1080/25785826.2024.2430812. Epub 2024 Nov 28. Immunol Med. 2025. PMID: 39607031 Free article.
4,837 results